Visits: 4379, Avg visit time (secs): 247,00 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1796 | 41,01% | |
| /recipients.html | 705 | 16,10% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 183 | 4,18% |
| /lilly/efsd-lilly-recipients.html | 139 | 3,17% |
| /lilly/efsd-cds-lilly-recipients.html | 90 | 2,06% |
| /jnj/efsd-jnj-recipients.html | 78 | 1,78% |
| /msd/efsd-msd-recipients.html | 75 | 1,71% |
| /novartis/efsd-novartis-recipients.html | 60 | 1,37% |
| /servier/efsd-servier-recipients.html | 59 | 1,35% |
| /gsk/efsd-gsk-recipients.html | 58 | 1,32% |
| /efsd-grant/efsd-clinres-recipients.html | 56 | 1,28% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1997 | 45,60% |
| /lilly/efsd-lilly-recipients.html | 338 | 7,72% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 183 | 4,18% |
| /programmes.html | 119 | 2,72% |
| /home.html | 114 | 2,60% |
| /gsk/efsd-gsk-recipients.html | 113 | 2,58% |
| /jnj/efsd-jnj-recipients.html | 95 | 2,17% |
| /reports.html | 88 | 2,01% |
| /msd/efsd-msd-recipients.html | 84 | 1,92% |
| /lifescan/efsd-lifescan-recipients.html | 65 | 1,48% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 60 | 1,37% |